Swedish Orphan Biovitrum : 22 March – Phase 3 study results SEL-212 (transcript)
You efficacy and point and we're highly statistically significant, which of course is the first thing. 0:0:6.780 --> 0:0:37.30 Peter... | March 27, 2023
Stay updated with breaking news from Anders Ullman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
You efficacy and point and we're highly statistically significant, which of course is the first thing. 0:0:6.780 --> 0:0:37.30 Peter... | March 27, 2023
--75% of subjects in the DISSOLVE I extension phase on active treatment were responders through 12 months of...
--75% of subjects in the DISSOLVE I extension phase on active treatment were responders through 12 months of...
/PRNewswire/ -- Selecta Biosciences, Inc. (NASDAQ: SELB) and Sobi®, today announced positive topline results from the Phase 3 DISSOLVE I & II placebo...
--75% of subjects in the DISSOLVE I extension phase on active treatment were responders through 12 months of...